Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Income towards Parent Company (2016 - 2025)

Abeona Therapeutics has reported Income towards Parent Company over the past 15 years, most recently at -$20.5 million for Q4 2025.

  • Quarterly results put Income towards Parent Company at -$20.5 million for Q4 2025, down 120.17% from a year ago — trailing twelve months through Dec 2025 was $78.0 million (up 264.42% YoY), and the annual figure for FY2025 was $71.2 million, up 211.69%.
  • Income towards Parent Company for Q4 2025 was -$20.5 million at Abeona Therapeutics, down from -$5.2 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for ABEO hit a ceiling of $124.3 million in Q2 2025 and a floor of -$46.7 million in Q4 2021.
  • Median Income towards Parent Company over the past 5 years was -$13.2 million (2022), compared with a mean of -$8.1 million.
  • Biggest five-year swings in Income towards Parent Company: plummeted 194.85% in 2021 and later soared 1578.98% in 2025.
  • Abeona Therapeutics' Income towards Parent Company stood at -$46.7 million in 2021, then skyrocketed by 71.9% to -$13.1 million in 2022, then fell by 1.56% to -$13.3 million in 2023, then surged by 30.22% to -$9.3 million in 2024, then tumbled by 120.17% to -$20.5 million in 2025.
  • The last three reported values for Income towards Parent Company were -$20.5 million (Q4 2025), -$5.2 million (Q3 2025), and $124.3 million (Q2 2025) per Business Quant data.